General Information of DTT (ID: TTMK3EX)

DTT Name LanC-like protein 2 (LANCL2) DTT Info
Gene Name LANCL2

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Omilancor DM595I9 Ulcerative colitis DD71 Phase 2 [1]
LABP-104 DMMYYB9 Rheumatoid arthritis FA20 Phase 1 [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Correction to: Efficacy, Safety, and Tolerability of ?Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis. Inflamm Bowel Dis. 2022 Dec 1;28(12):1938.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight